Revised cardiac risk index (RCRI) is a useful tool for evaluation of perioperative cardiac morbidity in kidney transplant recipients

Transplantation

Volumn 96, Issue 7, 2013, Pages 639-643

  Hoftman, Nir ^a   Prunean, Adrian ^a   Dhillon, Anahat ^a   Danovitch, Gabriel M ^a   Lee, Michael S ^a   Gritsch, Hans Albin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cardiovascular disease; Complication; Kidney transplant; Mortality; Risk index

Indexed keywords

TROPONIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; COMPLETE HEART BLOCK; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GRAFT RECIPIENT; HEART DEATH; HEART VENTRICLE FIBRILLATION; HIGH RISK PATIENT; HUMAN; KIDNEY TRANSPLANTATION; MALE; MEDICAL HISTORY; MEDICAL RECORD REVIEW; MORBIDITY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; REVISED CARDIAC RISK INDEX; RISK ASSESSMENT; RISK REDUCTION; STENT THROMBOSIS;

ADULT; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; BIOLOGICAL MARKERS; CORONARY ANGIOGRAPHY; DECISION SUPPORT TECHNIQUES; FEMALE; HEART DISEASES; HUMANS; KIDNEY TRANSPLANTATION; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; TREATMENT OUTCOME; TROPONIN;

EID: 84885426381     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31829e2703     Document Type: Article

References (16)

1. Lentine KL, Brennan DC, Schnitzler MA. Incidence and predictors of myocardial infarction after kidney transplantation. J Am Soc Nephrol 2005; 16: 496.
2. Kasiske BL, Maclean JR, Snyder JJ. Acute myocardial infarction and kidney transplantation. J Am Soc Nephrol 2006; 17: 900.
3. Ramanathan V, Goral S, Tanriover B, et al. Screening asymptomatic diabetic patients for coronary artery disease prior to renal transplantation. Transplantation 2005; 79: 1453.
4. Danovitch GM, Hariharan S, Pirsch JD, et al. Management of the waiting list for cadaveric kidney transplants: report of a survey and recommendations by the Clinical Practice Guidelines Committee of the American Society of Transplantation. J Am Soc Nephrol 2002; 13: 528.
5. Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol 2007; 50: 1707.
6. Lentine KL, Costa SP, Weir MR, et al. Cardiac disease evaluation and management among kidney and liver transplantation candidates: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. J Am Coll Cardiol 2012; 60: 434.
7. Soveri I, Holme I, Holdaas H, et al. A cardiovascular risk calculator for renal transplant recipients. Transplantation 2012; 94: 57.
8. Lee TH. Reducing cardiac risk in noncardiac surgery. N Engl J Med 1999; 341: 1838.
9. McQuarrie EP, Fellström BC, Holdaas H, et al. Cardiovascular disease in renal transplant recipients. J Ren Care 2010; 36: 136.
10. Kasiske BL, Ramos EL, Gaston RS, et al. The evaluation of renal transplant candidates: clinical practice guidelines. Patient Care and Education Committee of the American Society of Transplant Physicians. J Am Soc Nephrol 1995; 6: 1.
11. Leonardi G, Tamagnone M, Ferro M, et al. Assessment of cardiovascular risk in waiting-listed renal transplant patients: a single center experience in 558 cases. Clin Transplant 2009; 23: 653.
12. Scheeren TW, Wiesenack C, Gerlach H, et al. Goal-directed intraoperative fluid therapy guided by stroke volume and its variation in high-risk surgical patients: a prospective randomized multicentre study. J Clin Monit Comput 2013; 27: 225.
13. U.S. Renal Data System, USRDS 2012 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, National Institutes of Health, NationalInstituteofDiabetes and Digestive andKidney Diseases, Bethesda, MD, 2009. Vol. 2, Figure 7.26 at http://www.usrds.org.
14. Kastrati A, Neumann FJ, Mehilli J, et al. Bivalirudin versus unfractionated heparin during percutaneous coronary intervention. N Engl J Med 2008; 359: 688.
15. Devereaux PJ, Chan MT, Alonso-Coello P, et al. Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. JAMA 2012; 21: 2295.
16. Shroff GR, Shroff GR, Akkina SK, et al. Troponin I levels and postoperative myocardial infarction following renal transplantation. Am J Nephrol 2012; 35: 175.